Skip to main content
The University of Arizona Wordmark Line Logo White

Poison & Drug Info: 1-800-222-1222

R. Ken Coit College of Pharmacy | Home

APPLY

Give

DIRECTORY

I am
home home

Main navigation

  • Centers Publications
  • Academic Degrees Overview Undergraduate PharmD Master of Science Online MSPS Program PhD Degree Academic Programs
  • Directory Pharmacy Practice & Science Department Pharmacology & Toxicology Department National Advisory Board Alumni Council
  • Career Development
  • News Newsletters Faculty Awards Preceptor Awards Alumni and Community Awards Staff Awards Student Awards
  • Events
  • Fuel Wonder Campaign Homecoming Support RKCCOP Get Involved Update Contact Info
  1. Home
  2. Research Outreach
  3. Publications

2020

Cooper, L., Schafer, A., Li, X., Cheng, H., Fagla, B., Shen, Z., Nowar, R., Dye, K., Anantpadma, M., Davey, R., Thatcher, G., Rong, L., & Xiong, R. (2020). Screening and Reverse-Engineering of Estrogen Receptor Ligands as Potent Pan-Filovirus Inhibitors. 63(19). https://doi.org/10.1021/acs.jmedchem.0c01001
Wang, L., Chen, Q., Little, N., & Lu, J. (2020). Self-assembling Prodrug Nanotherapeutics for Synergistic Tumor Targeted Drug Delivery. https://doi.org/10.1016/j.actbio.2020.05.026
Vadiei, N., Chien, J., Enwereji, J., Myslinski, B., & Guzman, A. (2020). Start low, go fast? Antipsychotic titration patterns at an inpatient psychiatric hospital. 10(5). https://doi.org/10.9740/mhc.2020.09.275
Branco, P., Pontes, C., Rezende-Teixeira, P., Amengual-Rigo, P., Alves-Fernandes, D., Maria-Engler, S., da Silva, A., Pessoa, O., Jimenez, P., Mollasalehi, N., Chapman, E., Guallar, V., Machado-Neto, J., & Costa-Lotufo, L. (2020). Survivin modulation in the antimelanoma activity of prodiginines. 888. https://doi.org/10.1016/j.ejphar.2020.173465
Madasu, C., Karri, S., Sangaraju, R., Sistla, R., & Uppuluri, M. (2020). Synthesis and biological evaluation of some novel 1,2,3-triazole hybrids of myrrhanone B isolated from Commiphora mukul gum resin: Identification of potent antiproliferative leads active against prostate cancer cells (PC-3). 188.
Kim, M., Jung, S.-O., Kim, M., & Abraham, I. (2020). Systematic review of longitudinal studies on chemotherapy-associated subjective cognitive impairment in cancer patients. 29(4). https://doi.org/10.1002/pon.5339
Tharappel, A., Samrat, S., Li, X., & Li, X. (2020). Targeting crucial host factors of SARS-CoV-2.
Gao, J., Wang, L., Gao, J., Arakawa, H., Perry, G., & Wang, L. (2020). TDP-43 inhibitory peptide alleviates neurodegeneration and memory loss in an APP transgenic mouse model for Alzheimer’s disease. 1866(1). https://doi.org/10.1016/j.bbadis.2019.165580
Leonardi, A., Kovalchuk, N., Yin, L., Endres, L., Evke, S., Nevins, S., Martin, J., Dedon, P., Melendez, A., Van Winkle, L., Zhang, D., Ding, X., & Begley, T. (2020). The epitranscriptomic writer ALKBH8 drives tolerance and protects mouse lungs from the environmental pollutant naphthalene. 15(10). https://doi.org/10.1080/15592294.2020.1750213
Edwards, C., Miller, A., Cobb, P., & Erstad, B. (2020). The pharmacist’s role in disaster research response. 77(13). https://doi.org/10.1093/ajhp/zxaa093
Alkhatib, N., & Abraham, I. (2020). The six Delta platform for outcome-based contracting for pharmaceuticals. 23(11). https://doi.org/10.1080/13696998.2020.1824161

2019

Fazel, M., Cooley, J., Kurdi, S., & Fazel, M. (2019). A co-curricular diabetes-specific elective with interprofessional students and faculty. 11(2). https://doi.org/10.1016/j.cptl.2018.11.006
Almutairi, A., Mollon, L., Lee, J., & Slack, M. (2019). A comparison of the pharmacologic and nonpharmacologic strategies used to manage chronic pain: Opioid users versus nonusers. 59(5). https://doi.org/10.1016/j.japh.2019.06.009
Gallo, T., Curry, S., Padilla-Jones, A., Heise, C., Ramos, K., Woosley, R., & Raschke, R. (2019). A computerized scoring system to improve assessment of heparin-induced thrombocytopenia risk. 17(2). https://doi.org/10.1111/jth.14359
Ma, C., Hu, S., Zhang, D., Musharrafieh, R., & Wang, L. (2019). A Novel Capsid Binding Inhibitor Displays Potent Antiviral Activity against Enterovirus D68. 5(11). https://doi.org/10.1021/acsinfecdis.9b00284
Eedara, B., Tucker, I., & Das, S. (2019). A STELLA simulation model for in vitro dissolution testing of respirable size particles. 9(1). https://doi.org/10.1038/s41598-019-55164-0
Karnes, J., Miller, A., White, L., Konvinse, K., Pavlos, R., Redwood, A., Peter, J., Lehloenya, R., Mallal, S., & Phillips, E. (2019). Applications of Immunopharmacogenomics: Predicting, Preventing, and Understanding Immune-Mediated Adverse Drug Reactions. 59. https://doi.org/10.1146/annurev-pharmtox-010818-021818
Tetuan, C., Axon, D., Bingham, J., Boesen, K., Lipsy, R., Scovis, N., Taylor, A., Warholak, T., Lott, B., & Leal, S. (2019). Assessing the Effect of a Telepharmacist’s Recommendations During an Integrated, Interprofessional Telehealth Appointment and Their Alignment with Quality Measures. 25(12). https://doi.org/10.18553/jmcp.2019.25.12.1334
Huntley, M., Gao, J., Termsarasab, P., Wang, L., Zeng, T., Thammongkolchai, T., Liu, P., Cohen, S., & Wang, L. (2019). Association between TDP-43 and mitochondria in inclusion body myositis. 99(7). https://doi.org/10.1038/s41374-019-0233-x
Alsuhebany, N., Alfehaid, L., Almodaimegh, H., Albekairy, A., & Alharbi, A. (2019). Attitude and Perception of Physicians and Nurses Toward the Role of Clinical Pharmacists in Riyadh, Saudi Arabia: A Qualitative Study. 5.
Haas, C., Appleman, L., Stein, M., Redlinger, M., Wilks, M., Xu, Y.- ming, Onorati, A., Kalavacharla, A., Kim, M., Zhen, C., Kadri, S., Segal, R., Gimotty, P., Davis, L., & Amaravadi, R. (2019). Autophagy Inhibition to Augment mTOR Inhibition: a Phase I/II Trial of Everolimus and Hydroxychloroquine in Patients with Previously Treated Renal Cell Carcinoma. 25(7). https://doi.org/10.1158/1078-0432.CCR-18-2204
Rangnekar, B., Momin, M., Eedara, B., Sinha, S., & Das, S. (2019). Bedaquiline containing triple combination powder for inhalation to treat drug-resistant tuberculosis. 570. https://doi.org/10.1016/j.ijpharm.2019.118689
Mi, Y., Yang, S., Bloomquist, C., Xia, M., Sun, B., Qi, Y., Wagner, K., Montgomery, S., Zhang, D., & Wang, L. (2019). Biologically Targeted Photo-Crosslinkable Nanopatch to Prevent Postsurgical Peritoneal Adhesion. 6(19).
Patanwala, A., Radosevich, J., Meshay, I., Naderi, M., Culver, M., Lee, J., Weinberg, J., Khobrani, M., & Nix, D. (2019). Cefazolin Monotherapy Versus Cefazolin Plus Aminoglycosides for Antimicrobial Prophylaxis of Type III Open Fractures. https://doi.org/10.1097/MJT.0000000000001121
Tate, J., Abraham, I., & Cranmer, L. (2019). Center-Specific Modeling Predicts Cancer Trial Accrual More Accurately Than Investigators and Random Effects Modeling at 16 Cancer Centers. 3. https://doi.org/10.1200/CCI.19.00005
Li, X., Fu, P., Green, C., Liu, P., Zhang, D., Lang, Y., Chaturvedi, A., Belfort, M., Liao, G., & Li, X. (2019). Cisplatin protects mice from challenge of by targeting the Prp8 intein. 8(1). https://doi.org/10.1080/22221751.2019.1625727
Andritsos, L., Huang, P.-L., Abraham, I., Huff, K., Scrape, S., Fan, X., Alkhatib, N., Hofmeister, C., Drea, E., & McBride, A. (2019). Clinical and cost outcomes of pre-emptive plerixafor administration in patients with multiple myeloma undergoing stem cell mobilization. 85. https://doi.org/10.1016/j.leukres.2019.106215
Almutairi, A., Alkhatib, N., Martin, J., Babiker, H., Garland, L., McBride, A., & Abraham, I. (2019). Comparative efficacy and safety of immunotherapies targeting the PD-1/PD-L1 pathway for previously treated advanced non-small cell lung cancer: A Bayesian network meta-analysis. 142. https://doi.org/10.1016/j.critrevonc.2019.07.004
Almulhim, A., Fallatah, S., & Abraham, I. (2019). Comparing incomparables with the wrong analytics: Anticoagulation, disability, intracranial hemorrhage, and mortality in acute cerebral vein thrombosis. 178. https://doi.org/10.1016/j.thromres.2019.04.009
Alhifany, A., Almutairi, A., Almangour, T., Shahbar, A., Abraham, I., Alessa, M., Alnezary, F., & Cheema, E. (2019). Comparing the efficacy and safety of faecal microbiota transplantation with bezlotoxumab in reducing the risk of recurrent infections: a systematic review and Bayesian network meta-analysis of randomised controlled trials. 9(11). https://doi.org/10.1136/bmjopen-2019-031145

Pagination

  • « First First page
  • ‹ Previous Previous page
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • Next › Next page
  • Last » Last page
R. Ken Coit College of Pharmacy | Home

Footer - Main

  • Contact Us
  • Professionalism Form
  • College Assets
  • Room Reservations
  • Internal Links
  • Employment
  • Emergency Information
  • Title IX
  • Campus Safety
  • Copyright
  • Accessibility

Information For

  • Future Students
  • Current Students
  • Faculty & Staff
  • Preceptors
  • Alumni
  • Donors

Topics

  • About the College
  • Why Choose RKCCOP?
  • Academics
  • Coit Museum of Pharmacy & Health Sciences
  • Environmental Health
  • Libraries
  • Research & Outreach
  • UArizona Health Sciences

Resources

  • A-Z Index
  • Events
  • Tucson Campus Map
  • Phoenix Campus Map
  • News
  • Weather

Connect

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • YouTube
  • Flickr
  • Spotify

We respectfully acknowledge the University of Arizona is on the land and territories of Indigenous peoples. Today, Arizona is home to 22 federally recognized tribes, with Tucson being home to the O’odham and the Yaqui. The University strives to build sustainable relationships with sovereign Native Nations and Indigenous communities through education offerings, partnerships, and community service.


University Information Security and Privacy

© 2025 The Arizona Board of Regents on behalf of The University of Arizona.